{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:21:29Z","timestamp":1792718489220,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:00:00Z","timestamp":1649203200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:00:00Z","timestamp":1649203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100006484","name":"Vifor Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s10620-022-07474-z","type":"journal-article","created":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T15:03:37Z","timestamp":1649257417000},"page":"5637-5646","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Iron Deficiency in Patients with Inflammatory Bowel Diseases: A Prospective Multicenter Cross-Sectional Study"],"prefix":"10.1007","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2536-6618","authenticated-orcid":false,"given":"Laurent","family":"Peyrin-Biroulet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Bouguen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Laharie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gauthier","family":"Pellet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Savoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrielle","family":"Gilletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Michiels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Buisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathurin","family":"Fumery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-No\u00ebl","family":"Trochu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Cacoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The CARENFER study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Macaigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Amil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lien","family":"Amiot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Locher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Kaassis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Nahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Benamouzig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Altwegg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Heluwaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Claude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Andrau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Veyrard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Dib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Andrieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Choukroun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Cohen-solal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Luporsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katell","family":"Peoc\u2019h","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,6]]},"reference":[{"key":"7474_CR1","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S0140-6736(15)60865-0","volume":"387","author":"A Lopez","year":"2016","unstructured":"Lopez A, Cacoub P, Macdougall IC, Peyrin-Biroulet L. Iron deficiency anaemia. Lancet. 2016;387:907\u2013916.","journal-title":"Lancet."},{"key":"7474_CR2","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1590\/s0004-2803.202000000-51","volume":"57","author":"RS Parra","year":"2020","unstructured":"Parra RS, Feitosa MR, da Ferreira SC, Rocha JJRD, Troncon LEA, F\u00c9res O. Anemia and iron deficiency in inflammatory bowel disease patients in a referral center in Brazil: prevalence and risk factors. Arq Gastroenterol. 2020;57:272\u2013277.","journal-title":"Arq Gastroenterol."},{"key":"7474_CR3","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nrgastro.2010.151","volume":"7","author":"J Stein","year":"2010","unstructured":"Stein J, Hartmann F, Dignass AU. Diagnosis and management of iron deficiency anemia in patients with IBD. Nat Rev Gastroenterol Hepatol. 2010;7:599\u2013610.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"7474_CR4","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1136\/gut.2003.035758","volume":"53","author":"C Gasche","year":"2004","unstructured":"Gasche C, Lomer MCE, Cavill I, Weiss G. Iron, anaemia, and inflammatory bowel diseases. Gut. 2004;53:1190\u20131197.","journal-title":"Gut."},{"key":"7474_CR5","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1136\/gut.2010.214312","volume":"61","author":"R Evstatiev","year":"2012","unstructured":"Evstatiev R, Gasche C. Iron sensing and signalling. Gut. 2012;61:933\u2013952.","journal-title":"Gut."},{"key":"7474_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/joim.13004","volume":"287","author":"MD Cappellini","year":"2020","unstructured":"Cappellini MD, Musallam KM, Taher AT. Iron deficiency anaemia revisited. J Intern Med. 2020;287:153\u2013170.","journal-title":"J Intern Med."},{"key":"7474_CR7","doi-asserted-by":"publisher","first-page":"14983","DOI":"10.1038\/s41598-020-72057-9","volume":"10","author":"P Cacoub","year":"2020","unstructured":"Cacoub P, Nicolas G, Peoc\u2019h K. Iron deficiency markers in patients undergoing iron replacement therapy: a 9-year retrospective real-world evidence study using healthcare databases. Sci Rep. 2020;10:14983.","journal-title":"Sci Rep."},{"key":"7474_CR8","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/apt.14922","volume":"48","author":"L Peyrin-Biroulet","year":"2018","unstructured":"Peyrin-Biroulet L, Lopez A, Cummings JRF, Dignass A, Detlie TE, Danese S. Review article: treating-to-target for inflammatory bowel disease-associated anaemia. Aliment Pharmacol Ther. 2018;48:610\u2013617.","journal-title":"Aliment Pharmacol Ther."},{"key":"7474_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/ecco-jcc\/jju009","volume":"9","author":"AU Dignass","year":"2015","unstructured":"Dignass AU, Gasche C, Bettenworth D et al. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis. 2015;9:211\u2013222.","journal-title":"J Crohns Colitis."},{"key":"7474_CR10","first-page":"9394060","volume":"2018","author":"A Dignass","year":"2018","unstructured":"Dignass A, Farrag K, Stein J. Limitations of serum ferritin in diagnosing iron deficiency in inflammatory conditions. Int J Chronic Dis. 2018;2018:9394060.","journal-title":"Int J Chronic Dis."},{"key":"7474_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/MIB.0000000000000953","volume":"23","author":"JK Hou","year":"2017","unstructured":"Hou JK, Gasche C, Drazin NZ et al. Assessment of gaps in care and the development of a care pathway for anemia in patients with inflammatory bowel diseases. Inflamm Bowel Dis. 2017;23:35\u201343.","journal-title":"Inflamm Bowel Dis."},{"key":"7474_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2147\/CEOR.S150900","volume":"10","author":"J Stein","year":"2018","unstructured":"Stein J, Haas JS, Ong SH et al. Oral versus intravenous iron therapy in patients with inflammatory bowel disease and iron deficiency with and without anemia in Germany - a real-world evidence analysis. Clinicoecon Outcomes Res. 2018;10:93\u2013103.","journal-title":"Clinicoecon Outcomes Res."},{"key":"7474_CR13","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1002\/ibd.20285","volume":"13","author":"C Gasche","year":"2007","unstructured":"Gasche C, Berstad A, Befrits R et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis. 2007;13:1545\u20131553.","journal-title":"Inflamm Bowel Dis."},{"key":"7474_CR14","unstructured":"https:\/\/www.has-sante.fr\/jcms\/c_1051506\/fr\/choix-des-examens-du-metabolisme-du-fer-en-cas-de-suspicion-de-carence-en-fer-rapport-d-evaluation; 2022 Accessed 15.02.22"},{"key":"7474_CR15","unstructured":"https:\/\/www.who.int\/vmnis\/indicators\/haemoglobin.pdf; 2022 Accessed 15.02.22"},{"key":"7474_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1155\/2005\/269076","volume":"19","author":"MS Silverberg","year":"2005","unstructured":"Silverberg MS, Satsangi J, Ahmad T et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19:5\u201336.","journal-title":"Can J Gastroenterol."},{"key":"7474_CR17","unstructured":"Turlot J-C, Petiot JF. Intervalles de confiance pour une proportion: lesquels doit-on enseigner\u202f? arXiv:150101136 [math, stat] 2015. Available at: http:\/\/arxiv.org\/abs\/1501.01136 Accessed from 19 Jun 2021."},{"key":"7474_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.gastrohep.2017.07.011","volume":"41","author":"C Gonz\u00e1lez Alay\u00f3n","year":"2018","unstructured":"Gonz\u00e1lez Alay\u00f3n C, Pedrajas Crespo C, Mar\u00edn Pedrosa S et al. Prevalence of iron deficiency without anaemia in inflammatory bowel disease and impact on health-related quality of life. Gastroenterol Hepatol. 2018;41:22\u201329.","journal-title":"Gastroenterol Hepatol."},{"key":"7474_CR19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0140-6736(20)32594-0","volume":"397","author":"S-R Pasricha","year":"2021","unstructured":"Pasricha S-R, Tye-Din J, Muckenthaler MU, Swinkels DW. Iron deficiency. Lancet. 2021;397:233\u2013248.","journal-title":"Lancet."},{"key":"7474_CR20","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1007\/s40265-013-0131-2","volume":"73","author":"F Gomoll\u00f3n","year":"2013","unstructured":"Gomoll\u00f3n F, Gisbert JP. Current management of iron deficiency anemia in inflammatory bowel diseases: a practical guide. Drugs. 2013;73:1761\u20131770.","journal-title":"Drugs."},{"key":"7474_CR21","doi-asserted-by":"publisher","first-page":"8523205","DOI":"10.1155\/2020\/8523205","volume":"2020","author":"M Stojkovic Lalosevic","year":"2020","unstructured":"Stojkovic Lalosevic M, Toncev L, Stankovic S et al. Hepcidin is a reliable marker of iron deficiency anemia in newly diagnosed patients with inflammatory bowel disease. Dis Markers. 2020;2020:8523205.","journal-title":"Dis Markers."},{"key":"7474_CR22","doi-asserted-by":"publisher","first-page":"e2308","DOI":"10.1097\/MD.0000000000002308","volume":"95","author":"S Bonovas","year":"2016","unstructured":"Bonovas S, Fiorino G, Allocca M et al. Intravenous versus oral iron for the treatment of anemia in inflammatory bowel disease: a systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2016;95:e2308.","journal-title":"Medicine (Baltimore)."},{"key":"7474_CR23","first-page":"CD013529","volume":"1","author":"M Gordon","year":"2021","unstructured":"Gordon M, Sinopoulou V, Iheozor-Ejiofor Z et al. Interventions for treating iron deficiency anaemia in inflammatory bowel disease. Cochrane Database Syst Rev. 2021;1:CD013529.","journal-title":"Cochrane Database Syst Rev."},{"key":"7474_CR24","doi-asserted-by":"publisher","first-page":"E1536","DOI":"10.3390\/jcm9051536","volume":"9","author":"F D\u2019Amico","year":"2020","unstructured":"D\u2019Amico F, Peyrin-Biroulet L, Danese S. Oral iron for patients with IBD: lessons learned at time of COVID-19 pandemic. J Clin Med. 2020;9:E1536.","journal-title":"J Clin Med."},{"key":"7474_CR25","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.clnu.2016.12.027","volume":"36","author":"A Forbes","year":"2017","unstructured":"Forbes A, Escher J, H\u00e9buterne X et al. ESPEN guideline: clinical nutrition in inflammatory bowel disease. Clin Nutr. 2017;36:321\u2013347.","journal-title":"Clin Nutr."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07474-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-022-07474-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07474-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T19:28:50Z","timestamp":1668194930000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-022-07474-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,6]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7474"],"URL":"https:\/\/doi.org\/10.1007\/s10620-022-07474-z","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,6]]},"assertion":[{"value":"12 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"L Peyrin-Biroulet reports personal fees from Galapagos, AbbVie, Janssen, Genentech, Ferring, Tillots, Celltrion, Takeda, Pfizer, Index Pharmaceuticals, Sandoz, Celgene, Biogen, Samsung Bioepis, Inotrem, Allergan, MSD, Roche, Arena, Gilead, Amgen, BMS, Vifor, Norgine, Mylan, Lilly, Fresenius Kabi, OSE Immunotherapeutics, Enthera, Theravance, Pandion Therapeutics, Gossamer Bio, Viatris, and Thermo Fisher; -Grants from Abbvie, MSD, Takeda, and Fresenius Kabi; and stock options from CTMA. G Bouguen received lecture fees from Abbvie, Ferring, MSD, Takeda, and Pfizer and consultant fees from Takeda and Janssen. D Laharie declares counseling, boards, transports or fees from Abbvie, Biogaran, Biogen, Ferring, HAC Pharma, Janssen, MSD, Novartis, Pfizer, Prometheus, Roche, Takeda, Theradiag and Tillots. G Savoye has received lecture fees from Vifor Pharma, Takeda, Pfizer, HAC Pharma, Abbvie, MSD, and Ferring France. This author has also received travel accommodations from Ferring, Abbvie, and MSD France as well as a research grant from Ferring. C Giletta has received lecture\/consulting fees from Abbvie, Takeda, Pfizer, Celltrion, and Janssen. C Michiels received lecture fees from MSD and Abbvie and invitations to congresses form MSD, Abbvie and Ferring. M Fumery received lecture and consultant fees form Abbvie, MSD, Takeda, Janssen, Celgene, Boehringer, Biogen, Amgen, Celltrion, Pfizer, Galapagos and Lilly. A. Buisson disclosed consulting fees for Abbvie, Amgen, Arena, Biogen, Celltrion, CTMA, Ferring, Janssen, MSD, Nexbiome, Pfizer, Roche, Takeda, and Tillots, as well as lecture fees for Abbvie, Amgen, Biogen, Janssen, Mayoly-Spindler, MSD, Norgine Pfizer, Roche, Takeda, Tillots, and Vifor Pharma. P. Cacoub received consultancies and honoraria from Vifor Pharma.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}